Norepinephrine Bitartrate Injection Shortage
Last Updated: June 7, 2022
Status: Current
Products Affected - Description
-
- Levophed injection, Pfizer, 1 mg/mL, 4 mL ampule, 10 count, NDC 00409-1143-04 - discontinued
- Norepinephrine injection, Teva, 1 mg/mL, 4 mL vial, 10 count, NDC 00703-1153-03 - discontinued
Reason for the Shortage
-
- Amneal has norepinephrine injection available.
- Baxter has norepinephrine injection available.
- Hikma has norepinephrine injection available.
- Mylan Institutional has norepinephrine injection available.
- Pfizer has Levophed vials available.
- Sandoz has norepinephrine injection available.
- Teva discontinued norepinephrine in April 2022.
Available Products
-
- Levophed injection, Pfizer, 1 mg/mL, 4 mL vial, 10 count, NDC 00409-3375-04
- Norepinephrine injection, Amneal, 1 mg/mL, 4 mL vial, 10 count, NDC 70121-1576-07
- Norepinephrine injection, Baxter, 1 mg/mL, 4 mL ampule, 10 count, NDC 36000-0162-10
- Norepinephrine injection, Hikma, 1 mg/mL, 4 mL vial, 10 count, NDC 00143-9318-10
- Norepinephrine injection, Mylan Institutional, 1 mg/mL, 4 mL vial, 10 count, NDC 67457-0852-04
- Norepinephrine injection, Sandoz, 1 mg/mL, 4 mL vial, 10 count, NDC 00781-3755-95
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated June 7, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 22, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.